Navigation Links
Novavax Announces Release Date of 2007 Third Quarter Financial Results and Investor Conference Call
Date:11/2/2007

ROCKVILLE, Md., Nov. 2 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2007 third quarter financial results in a press release to be issued after 8:00 a.m. Eastern Time on November 12, 2007. The Company will hold an investor conference call to discuss its financial results at 10:00 a.m. Eastern Time on November 12, 2007. The call will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of senior management. A question and answer session will follow the financial results overview. The dial-in number for the conference call is USA and Canada (888) 334 3032 International: (719) 325 2415.

A live audio webcast of the conference call will be available at http://www.novavax.com. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. A replay of the webcast will be available for 90 days after the webcast and a replay of the conference call will also be available by telephone beginning 1pm EST. November 12, 2007 through midnight November 19, 2007. To access the replay, dial (888) 203 1112 and enter pass code 5883744.

About Novavax, Inc.

Novavax Inc. is committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. Using the company's proprietary virus-like particle (VLP) and Novasome(R) adjuvant technologies, Novavax is developing vaccines to protect against H5N1 pandemic influenza, seasonal flu and other viral diseases. Novavax's particulate vaccines closely match disease-causing viruses while lacking the genetic material to cause disease, which provides potential for greater immune protection at lower doses than current vaccines. With an exclusive portable manufacturing system that allows
'/>"/>

SOURCE Novavax, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novavax Says Bird Flu Vaccines Effective
2. PM announces a new health care order for India
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. PowderMed Announces Needle-Less Flu Vaccine
10. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
11. Australian Government Announces Survey To Tackle Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...irstCall/ -- Allscripts-Misys Healthcare,Solution... Inc. (Allscripts or,the Company), today announce...ths ended November 30, 2008. , (Logo: http...SLOGO-b ) , The Company,s results for the t...de results from legacy Allscripts for the period o...
(Date:1/8/2009)...wire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MD...ent and chief,executive officer, will present at ... on Wednesday, January 14, at 10:00 a.m. Pacific T...sco. , Dr. Hung will provide an overview of... for Dimebon for Alzheimer,s and Huntington,s dise...
(Date:1/8/2009)...Newswire/ -- The Pew Charitable Trusts announced t...hemical and food safety programs, in its Health &a...formerly deputy staff director and general counsel... Works, brings nearly 25 years of experience in en..., , "We are excited to be joined by such an exp...
(Date:1/8/2009)...aditional risk factors, experts say , , ... signs -- or "biomarkers" -- of inflammation may p...person,s risk of stroke, new research says. , "...e markers does not change things much," said study...e Methodist DeBakey Heart & Vascular Center an...
Breaking Medicine News(10 mins):Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3
...from Durham University and two Polish institutions...tionships with their fathers are more likely to s...t, women who have negative or less positive relati...ooked like their male parents. Due to be publishe...
... with severe Parkinsons disease were able to walk,...after being injected with human neural stem cells,...ty of Colorado, and the Burnham Institute report t...Academy of Sciences. These results are promising,...
...reatment called photodynamic therapy (PDT) may be ...targeting local tumours , according to research pu...esday). PDT is a relatively new way of treating c...velopment and being researched in labs around the ...
...n state is ruled by Hindu zealots. But they seem t...IV/AIDS by encouraging distribution of condoms at ...officials say. Particularly making available cond... in Surat has succeeded in spreading awareness of ...
Other Medicine News:Health News:Women Choose Their Men With Their Fathers Resemblance 2Health News:Neural Stem Cells Reduce Parkinsons Symptoms in Monkeys 2Health News:Photodynamic Therapy can Scramble the Immune System to Fight Cancer Spread 2Health News:HIV Awareness Increases as Condoms are Distributed in Gujarat Theatres Screening Porn Films 2
(Date:1/5/2009)... Jan. 5 Cylene Pharmaceuticals ann...cal trial of its oral CK2 protein kinase inhibitor... Castleman,s disease, or multiple myeloma. The pri...re determination of safety, tolerance and PK prope...e for Phase II trials. In addition, multiple mecha...
(Date:12/30/2008)..., Dec. 30 The Coalition...tizen petition filed by Genentech, Inc. on Decembe...ratories to offer diagnostic tests to physicians a...laboratory tests, would harm patient care and rest...The Coalition,s mission is to encourage the resear...
(Date:12/27/2008)...oisselier breaks 5-year silence, offers to ease cl...ic , , LAS VEGAS, Dec. 27 /PRNewswire-USNewswir... Eve, the first cloned child, Dr. Brigitte Boissel...oject, said Eve and other babies cloned by her com...no one invading their families, privacy. , , "W...
(Date:12/17/2008)...if., Dec. 17 PEAK Surgical, Inc., ... tissue dissection system based on a,proprietary ... Drug,Administration (FDA) has granted the compan...System for cutting and coagulation of soft tissue ... and throat), gynecologic,orthopedic, arthroscop...
Breaking Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4'We're Ready to Prove It!' 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Highlights from the December 2007 Journal of the American Dietetic Association 1406 1Highlights from the December 2007 Journal of the American Dietetic Association 1406 2Bristol Myers Squibb New Jersey Childrens Hospital Launch Center for Immune System Disorders 26 Infectious Diseases Including HIV AIDS 955 1Bristol Myers Squibb New Jersey Childrens Hospital Launch Center for Immune System Disorders 26 Infectious Diseases Including HIV AIDS 955 2Bristol Myers Squibb New Jersey Childrens Hospital Launch Center for Immune System Disorders 26 Infectious Diseases Including HIV AIDS 955 3Bristol Myers Squibb New Jersey Childrens Hospital Launch Center for Immune System Disorders 26 Infectious Diseases Including HIV AIDS 955 4Bristol Myers Squibb New Jersey Childrens Hospital Launch Center for Immune System Disorders 26 Infectious Diseases Including HIV AIDS 955 5Evel Knievel Lost to Pulmonary Fibrosis 3B Disease Claims as Many Lives as Breast Cancer Each Year 7340 1Evel Knievel Lost to Pulmonary Fibrosis 3B Disease Claims as Many Lives as Breast Cancer Each Year 7340 2HCA Announces Completion of Sale of Cedars Medical Center 7336 1
...ndash; Intercell AG (VSE,“ICLL”) has ... Co., Inc. on the results of a Phase I study invol...mparing safety and,immunogenicity of different dos...aphylococcus aureus vaccine is based on a conserve...Antigen Identification,Program (AIP®) and was ...
.../PRNewswire-FirstCall/ -- A total,of 20 oral and p...ing-Plough,s hepatitis products, including PEGINTR...avirin, USP) combination,therapy for chronic hepat...r (SCH 503034), the company,s investigational oral...ical development, will,be presented by leading res...
Other Medicine Technology:Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 2Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7
...TLR (<1%) and stroke rate - demonstrating the Cord...bility., , , High Radial Strength: Easily w...ng lumen diameter with chronic outward force., ,...ning, low profile design, Cordis TRUMARK™ tec...
... point-of-care device for the qualitative detectio... TOX/See device can detect up to nine of the most ...es only a few drops of urine. Each TOX/See cassett... and ease of use. TOX/See features integrated test...
... point-of-care device for the qualitative detectio... TOX/See device can detect up to nine of the most ...es only a few drops of urine. Each TOX/See cassett... and ease of use. TOX/See features integrated test...
... point-of-care device for the qualitative detectio... TOX/See device can detect up to nine of the most ...es only a few drops of urine. Each TOX/See cassett... and ease of use. TOX/See features integrated test...
Medicine Products: